BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

722 related articles for article (PubMed ID: 9557891)

  • 1. Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK).
    Beighton P; De Paepe A; Steinmann B; Tsipouras P; Wenstrup RJ
    Am J Med Genet; 1998 Apr; 77(1):31-7. PubMed ID: 9557891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ehlers-Danlos syndrome--a historical review.
    Parapia LA; Jackson C
    Br J Haematol; 2008 Apr; 141(1):32-5. PubMed ID: 18324963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Up-to-date classification and multidisciplinary symptoms of Ehlers-Danlos syndromes].
    Ralovich FV; Kiss N; Horváth K; Kárpáti S; Medvecz M
    Orv Hetil; 2019 Apr; 160(16):603-612. PubMed ID: 30983397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Updates in Clinical and Genetics Aspects of Hypermobile Ehlers Danlos Syndrome.
    Forghani I
    Balkan Med J; 2019 Jan; 36(1):12-16. PubMed ID: 30063214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Ehlers-Danlos syndromes, rare types.
    Brady AF; Demirdas S; Fournel-Gigleux S; Ghali N; Giunta C; Kapferer-Seebacher I; Kosho T; Mendoza-Londono R; Pope MF; Rohrbach M; Van Damme T; Vandersteen A; van Mourik C; Voermans N; Zschocke J; Malfait F
    Am J Med Genet C Semin Med Genet; 2017 Mar; 175(1):70-115. PubMed ID: 28306225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 2017 international classification of the Ehlers-Danlos syndromes.
    Malfait F; Francomano C; Byers P; Belmont J; Berglund B; Black J; Bloom L; Bowen JM; Brady AF; Burrows NP; Castori M; Cohen H; Colombi M; Demirdas S; De Backer J; De Paepe A; Fournel-Gigleux S; Frank M; Ghali N; Giunta C; Grahame R; Hakim A; Jeunemaitre X; Johnson D; Juul-Kristensen B; Kapferer-Seebacher I; Kazkaz H; Kosho T; Lavallee ME; Levy H; Mendoza-Londono R; Pepin M; Pope FM; Reinstein E; Robert L; Rohrbach M; Sanders L; Sobey GJ; Van Damme T; Vandersteen A; van Mourik C; Voermans N; Wheeldon N; Zschocke J; Tinkle B
    Am J Med Genet C Semin Med Genet; 2017 Mar; 175(1):8-26. PubMed ID: 28306229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ehlers-Danlos syndrome--diagnosis and subclassification].
    Rand-Hendriksen S; Wekre LL; Paus B
    Tidsskr Nor Laegeforen; 2006 Aug; 126(15):1903-7. PubMed ID: 16915311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of the 2017 criteria for vascular Ehlers-Danlos syndrome in 50 patients ascertained according to the Villefranche nosology.
    Ritelli M; Rovati C; Venturini M; Chiarelli N; Cinquina V; Castori M; Colombi M
    Clin Genet; 2020 Feb; 97(2):287-295. PubMed ID: 31600821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of Clinical Diagnostic Criteria for Patients With Vascular Ehlers-Danlos Syndrome in a Tertiary Referral Centre.
    Henneton P; Albuisson J; Adham S; Legrand A; Mazzella JM; Jeunemaitre X; Frank M
    Circ Genom Precis Med; 2019 Mar; 12(3):e001996. PubMed ID: 30919682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ehlers-Danlos syndromes].
    Germain DP
    Ann Dermatol Venereol; 2017 Dec; 144(12):744-758. PubMed ID: 29032848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ehlers-Danlos syndrome: classifications, oral manifestations, and dental considerations.
    Abel MD; Carrasco LR
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Nov; 102(5):582-90. PubMed ID: 17052632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum of mucocutaneous, ocular and facial features and delineation of novel presentations in 62 classical Ehlers-Danlos syndrome patients.
    Colombi M; Dordoni C; Venturini M; Ciaccio C; Morlino S; Chiarelli N; Zanca A; Calzavara-Pinton P; Zoppi N; Castori M; Ritelli M
    Clin Genet; 2017 Dec; 92(6):624-631. PubMed ID: 28485813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ehlers-Danlos syndrome.
    Grahame R
    S Afr Med J; 2016 May; 106(6 Suppl 1):S45-6. PubMed ID: 27245524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ehlers-Danlos syndrome, classical type.
    Bowen JM; Sobey GJ; Burrows NP; Colombi M; Lavallee ME; Malfait F; Francomano CA
    Am J Med Genet C Semin Med Genet; 2017 Mar; 175(1):27-39. PubMed ID: 28192633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The international consortium on the Ehlers-Danlos syndromes.
    Bloom L; Byers P; Francomano C; Tinkle B; Malfait F;
    Am J Med Genet C Semin Med Genet; 2017 Mar; 175(1):5-7. PubMed ID: 28306227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypermobile Ehlers-Danlos syndrome: A review and a critical appraisal of published genetic research to date.
    Scicluna K; Formosa MM; Farrugia R; Borg I
    Clin Genet; 2022 Jan; 101(1):20-31. PubMed ID: 34219226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Well-defined clinical presentation of Ehlers-Danlos syndrome in patients with tenascin-X deficiency: a report of four cases.
    Hendriks AGM; Voermans NC; Schalkwijk J; Hamel BC; van Rossum MM
    Clin Dysmorphol; 2012 Jan; 21(1):15-18. PubMed ID: 21959861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Joint hypermobility, skin hyper-elasticity, connective tissue fragility: classical symptoms of Ehlers-Danlos syndrome].
    Häggblom L; Sanner G
    Lakartidningen; 1995 Dec; 92(50):4809-13. PubMed ID: 8538298
    [No Abstract]   [Full Text] [Related]  

  • 19. An acquired or heritable connective tissue disorder? A review of hypermobile Ehlers Danlos Syndrome.
    Martin A
    Eur J Med Genet; 2019 Jul; 62(7):103672. PubMed ID: 31102747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A framework for the classification of joint hypermobility and related conditions.
    Castori M; Tinkle B; Levy H; Grahame R; Malfait F; Hakim A
    Am J Med Genet C Semin Med Genet; 2017 Mar; 175(1):148-157. PubMed ID: 28145606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.